{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:45:24Z","timestamp":1789080324400,"version":"build-2803163510"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2008,7,7]],"date-time":"2008-07-07T00:00:00Z","timestamp":1215388800000},"content-version":"vor","delay-in-days":2501,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1046\/j.1365-2230.2001.00868.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:03:59Z","timestamp":1047377039000},"page":"463-468","source":"Crossref","is-referenced-by-count":20,"title":["Sentinel node biopsy in the management of malignant melanoma"],"prefix":"10.1093","volume":"26","author":[{"given":"R.","family":"Russell-Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Acland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,7,7]]},"reference":[{"key":"10.1046\/j.1365-2230.2001.00868.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archsurg.1992.01420040034005","article-title":"Technical details of intraoperative mapping for early stage melanoma","volume":"127","author":"Morton","year":"1992","journal-title":"Arch Surg"},{"key":"10.1046\/j.1365-2230.2001.00868.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00000658-199609000-00002","article-title":"Efficacy of an elective regional lymph node dissection of 1-4 mm thick melanomas for patients 60 years of age and younger","volume":"224","author":"Balch","year":"1996","journal-title":"Ann Surg"},{"key":"10.1046\/j.1365-2230.2001.00868.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S0140-6736(97)08260-3","article-title":"Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial","volume":"351","author":"Cascinelli","year":"1998","journal-title":"Lancet"},{"key":"10.1046\/j.1365-2230.2001.00868.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1200\/JCO.1999.17.3.976","article-title":"Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel node status in 612 stage i or ii melanoma patients","volume":"3","author":"Gerschenwald","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1365-2230.2001.00868.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1200\/JCO.2001.19.10.2674","article-title":"Comparison of PET scanning and sentinel node biopsy in the detection of micrometastases of primary cutaneous malignant melanoma","volume":"19","author":"Acland","year":"2001","journal-title":"J Clin Oncol"},{"issue":"Suppl. 1","key":"10.1046\/j.1365-2230.2001.00868.x-BIB6|cit6","first-page":"S77","article-title":"S100 levels are not useful in predicting micrometastatic disease in malignant melanoma","volume":"11","author":"Acland","year":"2001","journal-title":"Melanoma Res"},{"key":"10.1046\/j.1365-2230.2001.00868.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/jama.280.16.1410","article-title":"Molecular staging of malignant melanoma","volume":"280","author":"Shivers","year":"1998","journal-title":"JAMA"},{"key":"10.1046\/j.1365-2230.2001.00868.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1046\/j.1523-1747.2000.00925.x","article-title":"Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma","volume":"14","author":"Blaheta","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1046\/j.1365-2230.2001.00868.x-BIB9|cit9","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1002\/(sici)1097-0142(20000315)88:6<1484::aid-cncr29>3.0.co;2-d","article-title":"A new American Joint Committee on Cancer Staging System for Cutaneous Melanoma","volume":"88","author":"Balch","year":"2000","journal-title":"Cancer"},{"key":"10.1046\/j.1365-2230.2001.00868.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/bmj.321.7252.3","article-title":"Patocskai E. The argument against sentinel node biopsy for malignant melanoma (editorial)","volume":"321","author":"Meiron Thomas","year":"2000","journal-title":"Br Med J"},{"key":"10.1046\/j.1365-2230.2001.00868.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.1996.14.1.7","article-title":"Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684","volume":"14","author":"Kirkwood","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1365-2230.2001.00868.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1200\/JCO.2000.18.12.2444","article-title":"High and low-dose Interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E 1690\/S 9111\/c 9190","volume":"18","author":"Kirkwood","year":"2000","journal-title":"J Clin Oncol"},{"issue":"Suppl. 4","key":"10.1046\/j.1365-2230.2001.00868.x-BIB13|cit13","first-page":"50","article-title":"Relapse-free and overall survival are significantly prolonged by high-dose 1FN-alpha 2b (HD1) compared to vaccine GM2-KLH with QS21 (GMK Progenics) for high-risk resected Stage 11B-111 melanoma: Results of the Intergroup Phase III study","volume":"11","author":"Kirkwood","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1046\/j.1365-2230.2001.00868.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1200\/JCO.1994.12.5.1036","article-title":"Improved survival in Stage III melanoma patients with GM2 ganglioside","volume":"12","author":"Livingston","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1365-2230.2001.00868.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1097\/00006534-200005000-00007","article-title":"Sentinel lymph node biopsy for melanoma. Experience with 234 consecutive procedures","volume":"105","author":"Wagner","year":"2000","journal-title":"Plast Reconst Surg"},{"key":"10.1046\/j.1365-2230.2001.00868.x-BIB16|cit16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s002590050363","article-title":"Towards quality assurance of the sentinel node procedure in malignant melanoma patients: a single institution evaluation and a european survey","volume":"26","author":"Bongers","year":"1999","journal-title":"Eur J Nucl Med"},{"key":"10.1046\/j.1365-2230.2001.00868.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s10434-999-0144-y","article-title":"The progression of melanoma nodal metastases is dependent on tumour thickness of the primary lesion","volume":"6","author":"Haddad","year":"1999","journal-title":"Ann Surg Oncol"},{"issue":"Suppl. 1","key":"10.1046\/j.1365-2230.2001.00868.x-BIB18|cit18","first-page":"S12","article-title":"Surgical management of occult lymph node metastases","volume":"11","author":"Thompson","year":"2001","journal-title":"Melanoma Res"},{"issue":"Suppl. 1","key":"10.1046\/j.1365-2230.2001.00868.x-BIB19|cit19","first-page":"S89","article-title":"Functional alterations in dendritic cell activities from the sentinel lymph nodes in cutaneous melanoma","volume":"11","author":"Essner","year":"2001","journal-title":"Melanoma Res"},{"issue":"Suppl. 1","key":"10.1046\/j.1365-2230.2001.00868.x-BIB20|cit20","first-page":"S109","article-title":"mm) melanoma undergoing sentinel node biopsy","volume":"11","author":"Sumner","year":"2001","journal-title":"Melanoma Res"},{"key":"10.1046\/j.1365-2230.2001.00868.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10434-000-0087-9","article-title":"Long-term results of a multi-institutional randomised trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0-4.0 mm). Intergroup Melanoma Surgical Trial","volume":"7","author":"Balch","year":"2000","journal-title":"Ann Surg Oncol"},{"key":"10.1046\/j.1365-2230.2001.00868.x-BIB22|cit22","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1046\/j.1365-2168.2000.01362.x","article-title":"Reliability of sentinel lymph node biopsy for staging melanoma","volume":"87","author":"Jansen","year":"2000","journal-title":"Br J Surg"},{"key":"10.1046\/j.1365-2230.2001.00868.x-BIB23|cit23","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1054\/bjps.2000.3409","article-title":"Sentinel lymph node biopsy in malignant melanoma: a series of 100 consecutive patients","volume":"53","author":"Hettiaratchy","year":"2000","journal-title":"Br J Plast Surg"},{"key":"10.1046\/j.1365-2230.2001.00868.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00000658-199602000-00016","article-title":"Intraoperative radio\u00a0lymphoscintigraphy improves sentinel node identification for patients with melanoma","volume":"223","author":"Albertini","year":"1996","journal-title":"Ann Surg"},{"key":"10.1046\/j.1365-2230.2001.00868.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1007\/BF00801606","article-title":"The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanoma","volume":"22","author":"Pijpers","year":"1995","journal-title":"Eur J Nucl Med"},{"key":"10.1046\/j.1365-2230.2001.00868.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/bjs.1800811220","article-title":"Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy","volume":"81","author":"Van der Veen","year":"1994","journal-title":"Br J Surg"},{"key":"10.1046\/j.1365-2230.2001.00868.x-BIB27|cit27","first-page":"288","article-title":"WHO declares lymphatic mapping to be the standard of care for melanoma","volume":"13","year":"1999","journal-title":"Oncology"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2230.2001.00868.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2230.2001.00868.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1046\/j.1365-2230.2001.00868.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T12:01:26Z","timestamp":1676376086000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/26\/6\/463\/6628175"}},"subtitle":["SLN biopsy in management of MM"],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,9]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2230.2001.00868.x","archive":["Portico"],"relation":{},"ISSN":["0307-6938"],"issn-type":[{"value":"0307-6938","type":"print"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}